SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-高管 Bausch Christoph Lawrence
02/24 11:16
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-高管 Kropotova Alexandra
02/24 06:06
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-高管 Sullivan Eddie Joe
02/24 06:05
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-高管 King Michael
02/24 05:57
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-高管 Reich Samuel J
02/24 05:46
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)
02/15 07:07
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G:超过5%持股股东披露文件-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
02/14 20:06
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G/A:超过5%持股股东披露文件(修正)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%)等
02/14 19:32
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-首席执行官 Sullivan Eddie Joe
2023/12/08 21:00
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | SC 13G:超过5%持股股东披露文件-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等
2023/12/05 05:33
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-首席财务官 King Michael
2023/12/01 06:00
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-董事会执行主席 Reich Samuel J
2023/11/30 21:00
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-董事 Sessa Capital (Master), L.P.
2023/11/29 05:05
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-董事 Moin Andrew
2023/11/29 05:05
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-董事 Ellias Helen K.
2023/11/29 05:05
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 3:首次持股声明-董事 Ellias Helen K.
2023/11/23 05:30
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4/A:持股变动声明(修正)-董事 Moin Andrew
2023/11/16 10:10
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4/A:持股变动声明(修正)-董事 Sessa Capital (Master), L.P.
2023/11/16 05:30
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-董事 Moin Andrew
2023/11/15 08:00
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 4:持股变动声明-董事 Sessa Capital (Master), L.P.
2023/11/15 05:08
暂无数据
暂无数据